Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hossam Nada

Showing results (31-40 of 79) with videos related to

Pageof 8
Sort By:
RSC Advances|August 27, 2025
Phenotypic and targeted drug discovery in immune therapeutics: challenges, opportunities, and future directionsNelson García Vázquez, Hossam Nada, Saurabh Upadhyay, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
Surface Plasmon Resonance (SPR)-Based Workflow for High-Throughput Discovery of CD28-Targeted Small MoleculesLaura Calvo-Barreiro, Hossam Nada, Saurabh Upadhyay, et al.
Bioorganic & Medicinal Chemistry Letters|October 6, 2025
Design and validation of the first-in-class PROTACs for targeted degradation of the immune checkpoint LAG-3Nelson García Vázquez, Somaya A Abdel-Rahman, Hossam Nada, et al.
International Journal of Biological Macromolecules|March 13, 2026
Restoring amyloid clearance: Z17 promotes astrocytes to clear Alzheimer's plaques via CHI3L1 inhibitionHossam Nada, Longfei Zhang, Baljit Kaur, et al.
ACS Omega|June 26, 2023
Identification of Potent hDHODH Inhibitors for Lung Cancer via Virtual Screening of a Rationally Designed Small Combinatorial LibraryHossam Nada, Sungdo Kim, Suin Park, et al.
Computers in Biology and Medicine|January 15, 2022
Identification of novel discoidin domain receptor 1 (DDR1) inhibitors using E-pharmacophore modeling, structure-based virtual screening, molecular dynamics simulation and MM-GBSA approachesHossam Nada, Kyeong Lee, Lizaveta Gotina, et al.
Biorxiv : the Preprint Server for Biology|December 19, 2025
Restoring Amyloid Clearance via Astrocytes: Z17 Is a Selective Inhibitor of CHI3L1 in Alzheimers DiseaseHossam Nada, Longfei Zhang, Baljit Kaur, et al.
European Journal of Medicinal Chemistry|September 28, 2025
Discovery and validation of LAGi-DEL: A nanomolar LAG-3 inhibitor that reverses immune suppression in tumor-immune co-culture modelsHossam Nada, Laura Calvo-Barreiro, Somaya A Abdel-Rahman, et al.
International Journal of Molecular Sciences|July 2, 2021
The Journey of DDR1 and DDR2 Kinase Inhibitors as Rising Stars in the Fight Against CancerAhmed Elkamhawy, Qili Lu, Hossam Nada, et al.
RSC Medicinal Chemistry|February 9, 2026
Discovery of a CHI3L1-targeted small molecule modulating neuroinflammation in Alzheimer's disease <i>via</i> DNA-encoded library (DEL) screeningBaljit Kaur, Longfei Zhang, Hossam Nada, et al.
Pageof 8

Showing results (31-40 of 79) with videos related to

Sort By:
Pageof 8
RSC Advances|August 27, 2025
Phenotypic and targeted drug discovery in immune therapeutics: challenges, opportunities, and future directionsNelson García Vázquez, Hossam Nada, Saurabh Upadhyay, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
Surface Plasmon Resonance (SPR)-Based Workflow for High-Throughput Discovery of CD28-Targeted Small MoleculesLaura Calvo-Barreiro, Hossam Nada, Saurabh Upadhyay, et al.
Bioorganic & Medicinal Chemistry Letters|October 6, 2025
Design and validation of the first-in-class PROTACs for targeted degradation of the immune checkpoint LAG-3Nelson García Vázquez, Somaya A Abdel-Rahman, Hossam Nada, et al.
International Journal of Biological Macromolecules|March 13, 2026
Restoring amyloid clearance: Z17 promotes astrocytes to clear Alzheimer's plaques via CHI3L1 inhibitionHossam Nada, Longfei Zhang, Baljit Kaur, et al.
ACS Omega|June 26, 2023
Identification of Potent hDHODH Inhibitors for Lung Cancer via Virtual Screening of a Rationally Designed Small Combinatorial LibraryHossam Nada, Sungdo Kim, Suin Park, et al.
Computers in Biology and Medicine|January 15, 2022
Identification of novel discoidin domain receptor 1 (DDR1) inhibitors using E-pharmacophore modeling, structure-based virtual screening, molecular dynamics simulation and MM-GBSA approachesHossam Nada, Kyeong Lee, Lizaveta Gotina, et al.
Biorxiv : the Preprint Server for Biology|December 19, 2025
Restoring Amyloid Clearance via Astrocytes: Z17 Is a Selective Inhibitor of CHI3L1 in Alzheimers DiseaseHossam Nada, Longfei Zhang, Baljit Kaur, et al.
European Journal of Medicinal Chemistry|September 28, 2025
Discovery and validation of LAGi-DEL: A nanomolar LAG-3 inhibitor that reverses immune suppression in tumor-immune co-culture modelsHossam Nada, Laura Calvo-Barreiro, Somaya A Abdel-Rahman, et al.
International Journal of Molecular Sciences|July 2, 2021
The Journey of DDR1 and DDR2 Kinase Inhibitors as Rising Stars in the Fight Against CancerAhmed Elkamhawy, Qili Lu, Hossam Nada, et al.
RSC Medicinal Chemistry|February 9, 2026
Discovery of a CHI3L1-targeted small molecule modulating neuroinflammation in Alzheimer's disease <i>via</i> DNA-encoded library (DEL) screeningBaljit Kaur, Longfei Zhang, Hossam Nada, et al.
Pageof 8